4.7 Letter

Ethyl Glucuronide in Hair Is an Accurate Biomarker of Chronic Excessive Alcohol Use in Patients With Alcoholic Cirrhosis

Journal

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY
Volume 16, Issue 3, Pages 454-456

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.cgh.2017.08.019

Keywords

-

Funding

  1. Vlaamse Vereniging voor Gastroenterologie (Flemish Association of Gastroenterology)

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Surgery

Patients with a History of Bariatric Surgery Are 8 Years Younger at Presentation with Severe Alcoholic Hepatitis

Lukas Van Melkebeke, Annelotte G. C. Broekhoven, Tessa Ostyn, Hannelie Korf, Minneke J. Coenraad, Roman Vangoitsenhoven, Bart van der Schueren, Matthias Lannoo, Hannah Van Malenstein, Tania Roskams, Schalk van der Merwe, Frederik Nevens, Jef Verbeek

Summary: This study assessed the impact of prior bariatric surgery on patients presenting with severe alcoholic hepatitis. The results showed that patients who had prior bariatric surgery were younger at the diagnosis of hepatitis, but there were no significant differences in disease severity or outcome compared to patients without prior surgery. These findings support the need for early detection of alcohol use disorder in patients who underwent bariatric surgery, particularly Roux-en-Y gastric bypass.

OBESITY SURGERY (2023)

Article Surgery

Utility and prognostic value of diagnosing MAFLD in patients undergoing liver transplantation for alcohol-related liver disease

Benedict T. K. Vanlerberghe, Hannah van Malenstein, Mauricio Sainz-Bariga, Ina Jochmans, David Cassiman, Diethard Monbaliu, Schalk van der Merwe, Jacques Pirenne, Frederik Nevens, Jef Verbeek

Summary: Recently, the concept of metabolic dysfunction-associated fatty liver disease (MAFLD) has been proposed to replace non-alcoholic fatty liver disease (NAFLD). This study assessed the prevalence of MAFLD in ALD patients undergoing liver transplantation (LTx) and its impact on post-transplant outcomes.

CLINICAL TRANSPLANTATION (2023)

Article Gastroenterology & Hepatology

Same-session double EUS-guided bypass versus surgical gastroenterostomy and hepaticojejunostomy: an international multicenter comparison

Michiel Bronswijk, Giuseppe Vanella, Roy L. J. van Wanrooij, Jayanta Samanta, Jonas Lauwereys, Enrique Perez-Cuadrado-Robles, Giuseppe Dell'Anna, Jahnvi Dhar, Vikas Gupta, Hannah van Malenstein, Wim Laleman, Joris Jaekers, Halit Topal, Baki Topal, Stefano Crippa, Massimo Falconi, Marc G. Besselink, Nouredin Messaoudi, Paolo Giorgio Arcidiacono, Rastislav Kunda, Schalk Van der Merwe

Summary: Same-session double EUS-guided bypass achieves similar technical and clinical success and is associated with fewer overall and severe adverse events compared to surgical gastroenterostomy and hepaticojejunostomy. Median time to oral intake and hospital stay are significantly shortened in the EUS group. Despite a patient population with more comorbidities, EUS-guided bypass shows promise as a less invasive alternative to surgical double bypass.

GASTROINTESTINAL ENDOSCOPY (2023)

Article Gastroenterology & Hepatology

EUS-guided gastroenterostomy for management of malignant gastric outlet obstruction: a prospective cohort study with matched comparison with enteral stenting

Giuseppe Vanella, Giuseppe Dell'Anna, Gabriele Capurso, Patrick Maisonneuve, Michiel Bronswijk, Stefano Crippa, Domenico Tamburrino, Marina Macchini, Giulia Orsi, Andrea Casadei-Gardini, Luca Aldrighetti, Michele Reni, Massimo Falconi, Schalk van der Merwe, Paolo Giorgio Arcidiacono

Summary: This study aimed to report on the clinical outcomes of EUS-GE in a prospective cohort study and compared it with ES. The results showed that EUS-GE demonstrated excellent efficacy in treating mGOO, and had several clinically significant advantages over ES.

GASTROINTESTINAL ENDOSCOPY (2023)

Letter Gastroenterology & Hepatology

Letter to the Editor: Survival in placebo-treated patients with severe alcohol-associated hepatitis

Lukas Van Melkebeke, Lore Pollentier, Schalk van der Merwe, Frederik Nevens, Jef Verbeek

HEPATOLOGY (2023)

Article Virology

SARS-CoV-2 vaccine antibody response and breakthrough infections in transplant recipients

Benedict Vanlerberghe, Casper Vrij, Kris Bogaerts, Pieter Vermeersch, Katrien Lagrou, Geert Molenberghs, Filip Rega, Laurens J. Ceulemans, Dirk van Raemdonck, Ina Jochmans, Diethard Monbaliu, Jacques Pirenne, Tim Vanuytsel, Pieter Gillard, Helene Schoemans, Johan Van Cleemput, Dirk Kuypers, Robin Vos, Frederik Nevens, Jef Verbeek

Summary: This observational study investigated the effectiveness of SARS-CoV-2 vaccines and breakthrough infections in transplant recipients. It found significant variations in antibody response rates and rates of severe infections among different transplant types, which were modulated by specific risk factors. These findings highlight the importance of tailored COVID-19 prevention measures for transplant recipients.

JOURNAL OF MEDICAL VIROLOGY (2023)

Article Gastroenterology & Hepatology

Questionnaire PLD-complaint-specific assessment identifies need for therapy in polycystic liver disease: A multi-centric prospective study

Antoon Billiet, Frederik Temmerman, Walter Coudyzer, Natalie van den Ende, Isabelle Colle, Sven Francque, Stephane De Maeght, Filip Janssens, Hans Orlent, Dirk Sprengers, Jean Delwaide, Sofie Decock, Charlotte De Vloo, Christophe Moreno, Hannah van Malenstein, Schalk van der Merwe, Jef Verbeek, Frederik Nevens

Summary: Polycystic liver disease (PLD) can cause hepatomegaly and the primary goal of treatment is symptom relief. The role of disease-specific questionnaires in determining treatment thresholds and assessing therapy needs in PLD patients needs further investigation.

UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2023)

Article Cell Biology

Tracer metabolomics reveals the role of aldose reductase in glycosylation

Silvia Radenkovic, Anna N. Ligezka, Sneha S. Mokashi, Karen Driesen, Lynn Dukes-Rimsky, Graeme Preston, Luckio F. Owuocha, Leila Sabbagh, Jehan Mousa, Christina Lam, Andrew Edmondson, Austin Larson, Matthew Schultz, Pieter Vermeersch, David Cassiman, Peter Witters, Lesa J. Beamer, Tamas Kozicz, Heather Flanagan-Steet, Bart Ghesquiere, Eva Morava

Summary: Abnormal polyol metabolism, primarily associated with diabetes, is also involved in phosphomannomutase 2 congenital disorder of glycosylation (PMM2-CDG). A potential therapy for PMM2-CDG, epalrestat, inhibits aldose reductase (AR). This study reveals that PMM2 deficiency affects intracellular glucose flux, leading to increased polyol production, and epalrestat treatment improves the clinical and biochemical characteristics of PMM2-CDG individuals.

CELL REPORTS MEDICINE (2023)

Article Substance Abuse

Baclofen during alcohol detoxification reduces the need for additional diazepam: a randomized placebo-controlled trial

Cleo L. Crunelle, Sami Jegham, Nathalie Vanderbruggen, Frieda Matthys

Summary: This study found that low-dose baclofen can effectively reduce the symptoms of alcohol withdrawal in patients during detoxification. Baclofen 30 and 60 mg/day were well tolerated and reduced the need for diazepam. It may be a potential alternative or adjunct to benzodiazepines, but more research is needed to support its use.

ALCOHOL AND ALCOHOLISM (2023)

Letter Gastroenterology & Hepatology

Tailoring treatment to the circumstance: reasoning behind metal versus plastic drainage of pancreatic collections

Giuseppe Vanella, Michiel Bronswijk, Schalk Willem van der Merwe, Paolo Giorgio Arcidiacono

Article Endocrinology & Metabolism

Quality of life of adult patients with hereditary fructose intolerance

Lise E. F. Janssen, David Cassiman, Martijn C. G. J. Brouwers

Summary: Although patients with hereditary fructose intolerance generally have a good prognosis on a fructose-restricted diet, this study found that they scored lower on vitality and general mental health, and reported a greater social impact of the disease.

MOLECULAR GENETICS AND METABOLISM (2023)

Article Gastroenterology & Hepatology

Combined endoscopic mAnagement of BiliaRy and gastrIc OutLET obstruction (CABRIOLET Study): A multicenter retrospective analysis

Giuseppe Vanella, Michiel Bronswijk, Roy L. J. van Wanrooij, Giuseppe Dell'Anna, Wim Laleman, Hannah van Malenstein, Rogier P. Voermans, Paul Fockens, Schalk Van der Merwe, Paolo Giorgio Arcidiacono

Summary: Combined biliary obstruction and gastric outlet obstruction is a challenging clinical scenario. This study evaluated the effectiveness of different therapeutic combinations in treating double obstruction and found that EUS-GE+HGS or EUS-GE+TPS may result in superior stent patency.

DEN OPEN (2023)

Meeting Abstract Gastroenterology & Hepatology

Sequential BAVENO VI plus dedicated spleen stiffness measurement or a novel spleen-centered algorithm significantly enlarges non-invasive ruling out of high risk varices: results from an international derivation-validation cohort study

Emma Vanderschueren, Angelo Armandi, Wilhelmus Kwanten, Luisa Vonghia, Merle Marie Werner, Talal Merizian, Georg Semmler, Thomas Reiberger, Thomas Vanwolleghem, David Cassiman, Sven Francque, Joern Schattenberg, Wim Laleman

JOURNAL OF HEPATOLOGY (2023)

Meeting Abstract Gastroenterology & Hepatology

Distinct immunometabolic signatures in circulating immune cells define disease outcomes in acute-on-chronic liver failure

Rita Furtado Feio de Azevedo, Markus Boesch, Silvia Radenkovic, Marie Wallays, Lukas Van Melkebeke, Bram Boeckx, Gino Philips, Lena Smets, Wim Laleman, Philippe Meersseman, Alexander Wilmer, David Cassiman, Hannah Van Malenstein, Joan Claria, Frederik Nevens, Jef Verbeek, Richard Moreau, Vicente Arroyo, Dieter Lambrechts, Bart Ghesquiere, Hannelie Korf, Schalk van der Merwe

JOURNAL OF HEPATOLOGY (2023)

No Data Available